Scalzo Richard William insider trades
Scalzo Richard William has filed 37 Form 4s with the SEC that we hold, for Dyne Therapeutics, Inc. (DYN) (SVP, Head of Finance & Admin.) and Crescent Biopharma, INC. (CBIO) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 42 sales worth $8.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($30.2K). The largest single trade was a sale of 124,374 shares of Dyne Therapeutics, Inc. worth $4.0M, dated 2024-09-06. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-22 and the latest 2026-09-18.
Dyne Therapeutics, Inc. (DYN)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-20 | S, sale reported on Form 4 | 367 | $5.7K | 2021-09-22 | SEC |
| 2021-09-21 | S, sale reported on Form 4 | 492 | $7.9K | 2021-09-22 | SEC |
| 2022-03-11 | S, sale reported on Form 4 | 308 | $2.7K | 2022-03-14 | SEC |
| 2022-12-12 | S, sale reported on Form 4 | 312 | $3.4K | 2022-12-13 | SEC |
| 2023-03-14 | S, sale reported on Form 4 | 1,311 | $17.5K | 2023-03-15 | SEC |
| 2023-06-13 | S, sale reported on Form 4 | 1,390 | $17.3K | 2023-06-15 | SEC |
| 2023-06-13 | S, sale reported on Form 4 | 40,000 | $515.6K | 2023-06-15 | SEC |
| 2023-06-15 | S, sale reported on Form 4 | 10,000 | $120.3K | 2023-06-15 | SEC |
| 2023-09-12 | S, sale reported on Form 4 | 1,397 | $14.5K | 2023-09-13 | SEC |
| 2023-09-18 | S, sale reported on Form 4 | 1,290 | $12.1K | 2023-09-20 | SEC |
| 2023-12-04 | S, sale reported on Form 4 | 681 | $8.2K | 2023-12-06 | SEC |
| 2023-12-06 | S, sale reported on Form 4 | 1,872 | $22.5K | 2023-12-06 | SEC |
| 2023-12-11 | S, sale reported on Form 4 | 1,380 | $14.8K | 2023-12-12 | SEC |
| 2023-12-14 | S, sale reported on Form 4 | 2,376 | $28.6K | 2023-12-14 | SEC |
| 2024-01-03 | S, sale reported on Form 4 | 13,000 | $244.5K | 2024-01-04 | SEC |
| 2024-01-26 | S, sale reported on Form 4 | 13,000 | $316.4K | 2024-01-26 | SEC |
| 2024-02-29 | S, sale reported on Form 4 | 3,429 | $94.3K | 2024-03-01 | SEC |
| 2024-03-01 | S, sale reported on Form 4 | 564 | $16.2K | 2024-03-01 | SEC |
| 2024-03-01 | S, sale reported on Form 4 | 8,747 | $246.8K | 2024-03-01 | SEC |
| 2024-03-07 | S, sale reported on Form 4 | 2,273 | $58.8K | 2024-03-11 | SEC |
| 2024-03-08 | S, sale reported on Form 4 | 289 | $7.9K | 2024-03-12 | SEC |
| 2024-03-08 | S, sale reported on Form 4 | 55,208 | $1.5M | 2024-03-12 | SEC |
| 2024-03-08 | S, sale reported on Form 4 | 30,755 | $778.4K | 2024-03-12 | SEC |
| 2024-03-11 | S, sale reported on Form 4 | 1,082 | $27.8K | 2024-03-12 | SEC |
| 2024-03-11 | S, sale reported on Form 4 | 1,590 | $39.7K | 2024-03-12 | SEC |
| 2024-05-16 | S, sale reported on Form 4 | 2,126 | $60.0K | 2024-05-17 | SEC |
| 2024-05-16 | S, sale reported on Form 4 | 462 | $13.2K | 2024-05-17 | SEC |
| 2024-06-10 | S, sale reported on Form 4 | 1,590 | $48.1K | 2024-06-11 | SEC |
| 2024-06-11 | S, sale reported on Form 4 | 1,331 | $41.7K | 2024-06-11 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 310 | $14.3K | 2024-08-20 | SEC |
| 2024-08-19 | S, sale reported on Form 4 | 2,442 | $109.9K | 2024-08-20 | SEC |
| 2024-09-06 | S, sale reported on Form 4 | 1,700 | $55.5K | 2024-09-10 | SEC |
| 2024-09-06 | S, sale reported on Form 4 | 124,374 | $4.0M | 2024-09-10 | SEC |
| 2024-09-11 | S, sale reported on Form 4 | 1,468 | $46.8K | 2024-09-11 | SEC |
| 2024-09-18 | S, sale reported on Form 4 | 1,390 | $48.0K | 2024-09-19 | SEC |
| 2024-11-18 | S, sale reported on Form 4 | 2,735 | $77.1K | 2024-11-18 | SEC |
| 2024-12-11 | S, sale reported on Form 4 | 1,455 | $40.9K | 2024-12-11 | SEC |
| 2025-02-18 | S, sale reported on Form 4 | 2,488 | $34.7K | 2025-02-18 | SEC |
| 2025-03-05 | S, sale reported on Form 4 | 917 | $10.8K | 2025-03-07 | SEC |
| 2025-03-11 | S, sale reported on Form 4 | 1,343 | $15.3K | 2025-03-13 | SEC |
Crescent Biopharma, INC. (CBIO)
Counted from the Form 4 filings this reporting owner (SEC CIK 1789545) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
